Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Minority Interest (2020 - 2022)

Bio-Techne has reported Minority Interest over the past 3 years, most recently at -$759000.0 for Q2 2022.

  • Quarterly results put Minority Interest at -$759000.0 for Q2 2022, down 109.19% from a year ago — trailing twelve months through Jun 2022 was -$759000.0 (down 109.19% YoY), and the annual figure for FY2022 was -$759000.0, down 109.19%.
  • Minority Interest for Q2 2022 was -$759000.0 at Bio-Techne, up from -$1.1 million in the prior quarter.
  • Over the last five years, Minority Interest for TECH hit a ceiling of $8.9 million in Q4 2020 and a floor of -$1.1 million in Q1 2022.
  • Median Minority Interest over the past 3 years was $7.6 million (2021), compared with a mean of $4.4 million.
  • Biggest five-year swings in Minority Interest: plummeted 105.12% in 2021 and later crashed 112.42% in 2022.
  • Bio-Techne's Minority Interest stood at $8.9 million in 2020, then tumbled by 105.12% to -$458000.0 in 2021, then crashed by 65.72% to -$759000.0 in 2022.
  • The last three reported values for Minority Interest were -$759000.0 (Q2 2022), -$1.1 million (Q1 2022), and -$458000.0 (Q4 2021) per Business Quant data.